Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome

Abroad (travel likely)RecruitingPHASE3

Conditions

MYOCARDIAL INFARCTION

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hopital Pitié Salpetrière, Paris, IDF, France
Contact: Study coordinator (Michel MD ZEITOUNI, MD,PhD) · michel.zeitouni@aphp.fr · 33142165535
Contact: Study coordinator (Delphine BRUGIER, PhD) · delphine.brugier-ext@aphp.fr · 33142162918

Study leads

Michel ZEITOUNI, MD, PhD
Study Chair
Assistance Publique - Hôpitaux de Paris

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes

Myocardial Infarction · Acute Coronary Syndrome · Diabetes

Abroad (travel likely)RecruitingPHASE2, PHASE3

São Paulo, Brazil

Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction

Acute Myocardial Infarction

Abroad (travel likely)RecruitingPHASE3

Seoul, South Korea

PERIODONTAL HEALTH IN PATIENTS ACUTELY ADMITTED FOR MYOCARDIAL INFARCTION: A CASE CONTROL STUDY

Myocardial Infarction, Acute · Periodontitis

Abroad (travel likely)Recruiting

Aberdeen, United Kingdom

REGistry of Long-term AnTithrombotic TherApy-1

Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) · Peripheral Artery Disease

Abroad (travel likely)Recruiting

Moscow, Russia